Cargando…
Lesions of “uncertain malignant potential” in the breast (B3) identified with mammography screening
BACKGROUND: Core needle biopsy (CNB) is a standard diagnostic procedure in the setting of breast cancer screening. However, CNB may result in the borderline diagnoses of lesion of uncertain malignant potential (B3). The aim of this study was to access the outcome of lesions diagnosed as B3 category...
Autores principales: | Richter-Ehrenstein, Christiane, Maak, Katharina, Röger, Sonja, Ehrenstein, Tilman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097423/ https://www.ncbi.nlm.nih.gov/pubmed/30115017 http://dx.doi.org/10.1186/s12885-018-4742-6 |
Ejemplares similares
-
First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
por: Rageth, Christoph J., et al.
Publicado: (2016) -
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
por: Rageth, Christoph J., et al.
Publicado: (2018) -
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
por: Elfgen, Constanze, et al.
Publicado: (2023) -
Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
por: Rageth, Christoph J., et al.
Publicado: (2019) -
Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3)
por: Houssami, N, et al.
Publicado: (2007)